Share

cover art for Health Tech World Podcast

Health Tech World Podcast


Latest episode

  • What genetic testing can actually do for your health

    22:23|
    Health Tech World sits down with Ailidh Watson and Lily Barnett from Jeen to explore the reality behind genetic testing. The genetic counsellors break down what your genome can - and crucially, cannot - tell you about your health, from cancer risk to family planning decisions.

More episodes

View all episodes

  • PFA: A New Frontier in Atrial Fibrillation Treatment

    19:50|
    Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting over 1.4 million people in the UK alone. We speak with Dr Angelo Auricchio of Boston Scientific about an innovative technology—now recommended by NICE—that could help reduce waiting lists while also addressing the associated risks of stroke and heart failure.
  • Navigating Market Access and Reimbursement

    23:14|
    Ahead of his panel at the Prix Galien UK Forum on June 5, we speak to Dr Mel Walker about the biggest challenges and opportunities for companies looking to navigate market access in the UK and beyond.
  • Creating Meaningful Change with AI-Powered Care Tech

    42:03|
    We speak to Stephen Nyasamo and Robert Davies of The ValueCare Group about their mission to bridge the gap between AI innovation and compassionate, sustainable care
  • Transforming Brain Tumour Outcomes With Precision Radiotherapy

    22:52|
    Dr Arjun Sahgal talks to Health Tech World about how one next-generation platform is treading new ground in tackling aggressive brain cancer.
  • Navigating the healthcare events landscape

    26:29|
    Health Tech World speaks to Convenzis Group MD Dan Snape about the changing face of healthcare events and the challenge of keeping the conversation going after delegates return to the office.
  • Jimmy Carter - An Immunotherapy Legacy

    27:53|
    Late US President Jimmy Carter became a vocal advocate for immunotherapy after his melanoma was successfully treated with the drug pembrolizumab (Keytruda) in 2015. Cancer Research Institute CEO Dr Alicia Zhou discusses the President's role in accelerating awareness of immunotherapy, as well as the most recent progress in the field.